News
Regeneron Pharmaceuticals REGN announced that it has met the primary endpoint in a late-stage study evaluating Eylea HD (aflibercept) Injection 8 mg to treat patients with macular edema following ...
One of these medicines, Eylea, also blocks another substance called placental growth factor (PlGF) and may be an option for people with wet AMD. As you age, you may develop a condition that causes ...
Eylea (aflibercept) is a biologic drug prescribed to help prevent vision loss in certain situations. It’s a liquid solution given by healthcare professionals as an injection into the eye. Eylea ...
A higher dose of Regeneron and Bayer's Eylea given every three or four months has shown efficacy in a pair of clinical trials, in a big boost for the multibillion-dollar product. The two studies ...
Eylea and Eylea HD (aflibercept) are prescription drugs used to treat certain types of eye conditions. Each comes as a liquid solution given as an injection into the eye. The dosing schedules can ...
Now, the candidate has failed to match Eylea in a phase 3 trial, leaving the Australian biotech to consider its own future. The drug in question is sozinibercept, an inhibitor of vascular ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results